Buy One Get One free -Llimited Time Offer X
Gemacta, a prescription drug, is manufactured in various forms such as Injection. It is primarily used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer. Secondary and off-label uses of Gemacta have also been mentioned below.
The right dosage of Gemacta depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Gemacta can also lead to other problems, which have been listed below. Such side effects of Gemacta normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Gemacta has a Unknown effect for pregnant women and Severe effect on lactating mothers. Warnings related to Gemacta's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Heart Disease, Infections must refrain from the use of Gemacta since this can cause severe adverse effects. Other contraindications of Gemacta have been discussed in the sections ahead.
Drug reaction of Gemacta with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Gemacta is safe while driving, and is is addictive in nature.
Gemacta is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Gemacta is used -
Severe
Moderate
Mild
Is the use of Gemacta safe for pregnant women?
The effects of Gemacta on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Gemacta safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Gemacta. So it is adviced to consult the doctor before using it.
What is the effect of Gemacta on the Kidneys?
Very few cases of side effects of Gemacta on kidney have been reported.
What is the effect of Gemacta on the Liver?
The liver can be affected by Gemacta. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Gemacta only after medical advice.
What is the effect of Gemacta on the Heart?
Gemacta is rarely harmful for the heart.
Gemacta should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemacta unless your doctor advises you to do so -
Is this Gemacta habit forming or addictive?
Gemacta does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Gemacta since it will not make you feel sleepy.
Is it safe?
Gemacta is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Gemacta is unable to treat or cure mental disorders.
Interaction between Food and Gemacta
Due to the absence of research, it is difficult to say how Gemacta and food will interact.
Interaction between Alcohol and Gemacta
Due to lack of research, there is no information about the side effects of taking Gemacta with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614